Haemonetics Corp. (HAE) announced on Sunday that it entered into a definitive agreement to acquire the business assets of the blood collection, filtration and processing product lines of Pall Corp. (PLL).
Haemonetics also reported fourth quarter non-GAAP net income of $0.80 per share, down from $0.85 per share in the prior year. The consensus estimate was for EPS of $0.83. Full year 2013 adjusted EPS is expected to be between $3.30 and $3.40, compared to the consensus estimate of $3.50.
Haemonetics spiked to the upside at the open Monday, before settling into a range. The stock ended the day higher by 2.86 at $71.57, with volume at a 3-month high. Haemonetics climbed past resistance and set a new high for the year.
For comments and feedback: editorial@rttnews.com